$1 billion antibiotic venture fund launched

Published on:

Antibiotic resistance is a problem. One study from Europe found that in 2015 there were 33,110 deaths attributable to antibiotic resistance; accounting for morbidity as well, antibiotic resistance lead to a a decrease of 874,541 disability-adjusted life years. CDC data show that antibiotic resistant bacteria and fungi caused 35,900 deaths in 2019, 12,800 deaths due to Clostridioides difficile infections.

To fight this trend, large life sciences firms are teaming up with governments and non-governmental organizations to help fund antibiotic research. Endpoints reports:

Pfizer, Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Bayer Pharmaceuticals, Merck KGaA and the American Merck — one

Read more    Source: healthcare-economist.com

Leave a Reply